Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for retinitis pigmentosa 64 has been reported in the published literature.
No clinical trials have been registered for retinitis pigmentosa 64.
39 publications have been identified in PubMed for retinitis pigmentosa 64. Research spans Epidemiology / Natural History (38%), Diagnostic / Biomarker (15%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 15 | 38% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 8:41 AM UTC
Testing and diagnosis research
6 |
15% |
Laboratory research | 6 | 15% |
Patient case studies | 4 | 10% |
New treatment approaches | 3 | 8% |
Other research | 2 | 5% |
Clinical study results | 2 | 5% |
Research summaries | 1 | 3% |
Hasegawa T (2026). [PMID: 41670415](https://pubmed.ncbi.nlm.nih.gov/41670415/). *Invest Ophthalmol Vis Sci*. [Epidemiology / Natural History]
Hong Y (2026). [PMID: 41242591](https://pubmed.ncbi.nlm.nih.gov/41242591/). *Am J Ophthalmol*. [Epidemiology / Natural History]
Vasilev R (2026). [PMID: 42266935](https://pubmed.ncbi.nlm.nih.gov/42266935/). *Front Med (Lausanne)*. [Diagnostic / Biomarker]
Seyedtaghia MR (2026). [PMID: 40252141](https://pubmed.ncbi.nlm.nih.gov/40252141/). *Biochem Genet*. [Basic Science / Preclinical]
Al-Moujahed A (2026). [PMID: 41891913](https://pubmed.ncbi.nlm.nih.gov/41891913/). *Ophthalmic Surg Lasers Imaging Retina*. [Epidemiology / Natural History]
Liu Y (2026). [PMID: 41518077](https://pubmed.ncbi.nlm.nih.gov/41518077/). *Genesis*. [Gene Therapy / Novel Therapeutics]
Carpenter E (2026). [PMID: 41632744](https://pubmed.ncbi.nlm.nih.gov/41632744/). *Ophthalmic Res*. [Clinical Trial Publication]
Ruggeri ML (2026). [PMID: 42011186](https://pubmed.ncbi.nlm.nih.gov/42011186/). *Ther Adv Ophthalmol*. [Epidemiology / Natural History]
Moreira Martins P (2025). [PMID: 40701515](https://pubmed.ncbi.nlm.nih.gov/40701515/). *Arch Soc Esp Oftalmol (Engl Ed)*. [Case Report / Case Series]
Jung SH (2025). [PMID: 40560841](https://pubmed.ncbi.nlm.nih.gov/40560841/). *PLoS One*. [Diagnostic / Biomarker]